Jeddah Bioscan
Body: 

Jeddah Bioscan

Jeddah Bioscan was established in 2006, in Jeddah, KSA was part of the Kingdom’s efforts for encouraging public-private partnerships and to become the middle east focal point of highly advanced biotechnology and its supportive industries including health, industry, agriculture, commerce, and education as well as leading the country to the international biotechnology market.

Jeddah BioScan provides treatment for cancer patients. It provides products and services that help in the treatment of oncology disease by diagnosing cancer at molecular level and was the 1st & only Cyclotron (at the time of its creation), PET/CT Scan facility of Cancer's Molecular Diagnoses across the private sector of Saudi Market, for which we have concluded a strategic divestiture to our partner; King Faisal Specialist Hospital (one of most prominent medical institutes in Middle East).

Share Percentage: 
10.00
Portfolio Type: 
Previous